Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose intravenous iron in iron-deficient blood donors
2013-000327-14Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in iron deficiency anemia (IDA) comparing Intravenous ferric carboxymaltose with Oral iron control (2 arms). Started Sep 2013; status: completed.
02
Drugs
ferric carboxymaltoseIron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2013-000327-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000327-14.